BioLife Solutions, Inc. (BLFS)
36.37
-0.83
(-2.23%)
USD |
NASDAQ |
Aug 28, 16:00
36.39
+0.02
(+0.05%)
After-Hours: 20:00
BioLife Solutions Free Cash Flow : 7.987M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.987M |
| March 31, 2026 | 8.427M |
| December 31, 2025 | 10.64M |
| September 30, 2025 | 10.56M |
| June 30, 2025 | 11.45M |
| March 31, 2025 | 11.29M |
| December 31, 2024 | 4.904M |
| September 30, 2024 | 5.651M |
| June 30, 2024 | -3.912M |
| March 31, 2024 | -17.70M |
| December 31, 2023 | -18.88M |
| September 30, 2023 | -16.80M |
| June 30, 2023 | -11.88M |
| March 31, 2023 | -15.50M |
| December 31, 2022 | -18.87M |
| September 30, 2022 | -24.62M |
| June 30, 2022 | -24.00M |
| March 31, 2022 | -21.79M |
| December 31, 2021 | -12.98M |
| September 30, 2021 | -12.64M |
| June 30, 2021 | -12.94M |
| March 31, 2021 | 0.899M |
| December 31, 2020 | 2.012M |
| September 30, 2020 | 2.696M |
| June 30, 2020 | 4.364M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.067M |
| December 31, 2019 | 0.538M |
| September 30, 2019 | 2.285M |
| June 30, 2019 | 1.769M |
| March 31, 2019 | 2.643M |
| December 31, 2018 | 1.848M |
| September 30, 2018 | 2.174M |
| June 30, 2018 | 1.704M |
| March 31, 2018 | 1.019M |
| December 31, 2017 | 0.4613M |
| September 30, 2017 | -1.227M |
| June 30, 2017 | -2.365M |
| March 31, 2017 | -3.618M |
| December 31, 2016 | -5.584M |
| September 30, 2016 | -6.336M |
| June 30, 2016 | -6.857M |
| March 31, 2016 | -6.718M |
| December 31, 2015 | -5.894M |
| September 30, 2015 | -5.244M |
| June 30, 2015 | -4.494M |
| March 31, 2015 | -4.188M |
| December 31, 2014 | -3.752M |
| September 30, 2014 | -2.636M |
| June 30, 2014 | -1.810M |
| March 31, 2014 | -0.8431M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Repligen Corp. | 110.15M |
| Agilent Technologies, Inc. | 1.267B |
| Danaher Corp. | 5.466B |
| Thermo Fisher Scientific, Inc. | 7.318B |
| West Pharmaceutical Services, Inc. | 436.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 6.348M |
| Cash from Investing (Quarterly) | -1.579M |
| Cash from Financing (Quarterly) | -3.594M |
| Free Cash Flow Per Share (Quarterly) | 0.1052 |
| Free Cash Flow to Equity (Quarterly) | 4.304M |
| Free Cash Flow to Firm (Quarterly) | 5.185M |
| Free Cash Flow Yield | 0.45% |